Patriots Marcus Cannon Continuing to Recover from Lymphoma

Heralded New England Patriots rookie, Marcus Cannon, is not going to let anything keep him from the first day of training camp in August.

In an interview with the Fort Worth Star-Telegram, Cannon -- the remarkable TCU standout who discovered eight days prior to the NFL draft that he had non-Hodgkin’s lymphoma -- described the progress that he has made. With a chemotherapy treatment scheduled for this week, the extremely positive and upbeat rookie detailed his coping process throughout these eventful last few months.

"The first thing my mom and my dad told me to do is pray," Cannon told the Star-Telegram last week, "and here we are today. I'm a fifth-round Patriots draft pick, and half the mass I had is gone. For everybody who doesn't believe, here's your reason to believe. It's a miracle in itself that somebody with a life-threatening disease gets drafted."

Interestingly enough, Cannon initially discovered a lump on his lower abdomen when he was 15 years old. When he questioned doctors about it, he was told that "it was an infection and would go away." However, when the lump began to get noticeably larger, the former TCU star realized that he needed to get himself checked out a little more closely.

"It was pretty shocking," Cannon's father, Ebbie Cannon, told the Star-Telegram about the diagnosis. "We had never had cancer in our family. We thought maybe it was a mistake or something."

Despite the fact that teams were told by doctors that there was a 90 percent chance of recovery from the disorder, Cannon ended up falling to the fifth round before being scooped up by the Patriots. A chance was all this young man needed, and that’s precisely what he got from one of the most respected franchises in all of sports.

"All I can do is keep doing what I'm doing," Cannon said. "That's to keep praying and accept my healing."

In league full of instability, drama and unfortunate headlines, New England’s rookie serves as a reminder of what’s truly important in life.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap